| Name | sodium,2-[3-[[(1S)-2-(4,5-diphenyl-1,3-oxazol-2-yl)cyclohex-2-en-1-yl]methyl]phenoxy]acetate | 
|---|---|
| Synonyms | 
                                
                                Acetic acid,(3-((2-(4,5-diphenyl-2-oxazolyl)-2-cyclohexen-1-yl)methyl)phenoxy)-,sodium salt,(S)
                                
                                
                                 Acetic acid,(3-(((1S)-2-(4,5-diphenyl-2-oxazolyl)-2-cyclohexen-1-yl)methyl)phenoxy)-,sodium salt  | 
                        
| Description | FR181157, an orally active PGI2 agonist activity with especially good pharmacokinetic properties[1]. | 
|---|---|
| Related Catalog | |
| In Vitro | FR181157 exhibits high binding affinity for the IP receptor with a Ki of 54 nM and anti-aggregative potency with an IC50 of 60 nM[1]. | 
| References | 
| Molecular Formula | C30H26NNaO4 | 
|---|---|
| Molecular Weight | 487.52 | 
| Exact Mass | 487.17600 | 
| PSA | 75.39000 | 
| LogP | 5.56350 |